SpringWorks Therapeutics Inc (SWTX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current SWTX market cap is 3.07B. The company's latest EPS is USD -3.4447 and P/E is -11.75.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.45M | 21.01M | 59.73M | 49.3M | 61.55M |
| Operating Income | -100.3M | -94.96M | -46.7M | -59.75M | -82.73M |
| Net Income | -94.32M | -87.39M | -39.92M | -53.53M | -77.3M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 35M | 0 | 0 | 5.45M | 191.59M |
| Operating Income | -46.93M | -174.46M | -283.56M | -348.05M | -284.13M |
| Net Income | -45.57M | -173.91M | -277.42M | -325.1M | -258.13M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 725.79M | 656.83M | 617.33M | 608.88M | 587.28M |
| Total Liabilities | 99.57M | 89.39M | 60.6M | 76.3M | 106.17M |
| Total Equity | 626.22M | 567.44M | 556.73M | 532.58M | 481.1M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 576.19M | 452.49M | 630.24M | 725.79M | 587.28M |
| Total Liabilities | 19.13M | 30.1M | 72.05M | 99.57M | 106.17M |
| Total Equity | 557.06M | 422.4M | 558.19M | 626.22M | 481.1M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -222.8M | -78.93M | -120.72M | -146.1M | -175.6M |
| Investing | 34.75M | 21.46M | 21.75M | 50.4M | 64.55M |
| Financing | 296.64M | -552k | 2.82M | 4.11M | 4.76M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -32.19M | -127.88M | -161.56M | -222.8M | -175.6M |
| Investing | -418.83M | 83.59M | -215.6M | 34.75M | 64.55M |
| Financing | 270.49M | 1.16M | 340.7M | 296.64M | 4.76M |
| Market Cap | 3.07B |
| Price to Earnings Ratio | -11.75 |
| Price to Sales Ratio | 15.83 |
| Price to Cash Ratio | 43.47 |
| Price to Book Ratio | 6.3 |
| Dividend Yield | - |
| Shares Outstanding | 74.94M |
| Average Volume (1 week) | 1.46M |
| Average Volume (1 Month) | 2.09M |
| 52 Week Change | 0.42% |
| 52 Week High | 62.00 |
| 52 Week Low | 28.21 |
| Spread (Intraday) | 1.4 (3.4%) |
| Company Name | SpringWorks Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.springworkstx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
